Coagulant Therapeutics

Coagulant Therapeutics ( ㈜코애귤런트테라퓨틱스는 중증산후출혈) is a biotechnology company seeking to address acute bleeding. It develops a proprietary rFVIIa molecule, termed CT-001, for the safe pharmaceutical intervention for the treatment of acute bleeding.